| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cientificas (CSIC) y Universidad Autonoma de Madrid (UAM), Arturo Duperier, 4, 28029-Madrid, Spain. gmorreale@iib.uam.es
The present comments are restricted to the role of maternal thyroid hormone on early brain development, and are based mostly on information presently available for the human fetal brain. It emphasizes that maternal hypothyroxinemia - defined as thyroxine (T4) concentrations that are low for the stage of pregnancy - is potentially damaging for neurodevelopment of the fetus throughout pregnancy, but especially so before midgestation, as the mother is then the only source of T4 for the developing brain.Despite a highly efficient uterine-placental 'barrier' to their transfer, very small amounts of T4 and triiodothyronine (T3) of maternal origin are present in the fetal compartment by 4 weeks after conception, with T4 increasing steadily thereafter. A major proportion of T4 in fetal fluids is not protein-bound: the 'free' T4 (FT4) available to fetal tissues is determined by the maternal serum T4, and reaches concentrations known to be of biological significance in adults. Despite very low T3 and 'free' T3 (FT3) in fetal fluids, the T3 generated locally from T4 in the cerebral cortex reaches adult concentrations by midgestation, and is partly bound to its nuclear receptor. Experimental results in the rat strongly support the conclusion that thyroid hormone is already required for normal corticogenesis very early in pregnancy.The first trimester surge of maternal FT4 is proposed as a biologically relevant event controlled by the conceptus to ensure its developing cerebral cortex is provided with the necessary amounts of substrate for the local generation of adequate amounts of T3 for binding to its nuclear receptor. Women unable to increase their production of T4 early in pregnancy would constitute a population at risk for neurological disabilities in their children. As mild-moderate iodine deficiency is still the most widespread cause of maternal hypothyroxinemia in Western societies, the birth of many children with learning disabilities may already be preventable by advising women to take iodine supplements as soon as pregnancy starts, or earlier if possible.
This article has been cited by other articles:
|
|
 |
|
  A. Peri and M. Serio Neuroprotective effects of the Alzheimer's disease-related gene seladin-1 J. Mol. Endocrinol., November 1, 2008; 41(5): 251 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sanchez-Vega, F. Escobar del Rey, H. Farinas-Seijas, and G. Morreale de Escobar Inadequate iodine nutrition of pregnant women from Extremadura (Spain) Eur. J. Endocrinol., October 1, 2008; 159(4): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Carroll, P. G. Arbogast, J. A. Dudley, and W. O. Cooper Increase in Incidence of Medically Treated Thyroid Disease in Children With Down Syndrome After Rerelease of American Academy of Pediatrics Health Supervision Guidelines Pediatrics, August 1, 2008; 122(2): e493 - e498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Benvenuti, P Luciani, I Cellai, C Deledda, S Baglioni, R Saccardi, S Urbani, F Francini, R Squecco, C Giuliani, et al. Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors J. Endocrinol., May 1, 2008; 197(2): 437 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Wasserman, K. Nelson, N. R. Rose, W. Eaton, J. P. Pillion, E. Seaberg, M. V. Talor, L. Burek, A. Duggan, and R. H. Yolken Maternal Thyroid Autoantibodies during the Third Trimester and Hearing Deficits in Children: An Epidemiologic Assessment Am. J. Epidemiol., March 15, 2008; 167(6): 701 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wallis, M. Sjogren, M. van Hogerlinden, G. Silberberg, A. Fisahn, K. Nordstrom, L. Larsson, H. Westerblad, G. Morreale de Escobar, O. Shupliakov, et al. Locomotor Deficiencies and Aberrant Development of Subtype-Specific GABAergic Interneurons Caused by an Unliganded Thyroid Hormone Receptor {alpha}1 J. Neurosci., February 20, 2008; 28(8): 1904 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sadakata, M. Washida, N. Morita, and T. Furuichi Tissue Distribution of Ca2+-dependent Activator Protein for Secretion Family Members CAPS1 and CAPS2 in Mice J. Histochem. Cytochem., March 1, 2007; 55(3): 301 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Domine, A-S Parent, G Rasier, M-C Lebrethon, and J-P Bourguignon Assessment and mechanism of variations in pubertal timing in internationally adopted children: a developmental hypothesis Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S17 - S25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Pearce, J. G. Hollowell Jr., G. Morreale de Escobar, F. Escobar del Rey, and R. D. Utiger Iodine Nutrition -- More Is Better N. Engl. J. Med., October 5, 2006; 355(14): 1500 - 1501. [Full Text] [PDF]
|
|
|
|
 |
|
 Hypothyroidism in the pregnant woman DTB, July 1, 2006; 44(7): 53 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. De Groef, B. R Decallonne, S. Van der Geyten, V. M Darras, and R. Bouillon Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects. Eur. J. Endocrinol., July 1, 2006; 155(1): 17 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Boas, U. Feldt-Rasmussen, N. E Skakkebaek, and K. M Main Environmental chemicals and thyroid function. Eur. J. Endocrinol., May 1, 2006; 154(5): 599 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Roberts, M. Srinivas, D. Forrest, G. Morreale de Escobar, and T. A. Reh Making the gradient: Thyroid hormone regulates cone opsin expression in the developing mouse retina PNAS, April 18, 2006; 103(16): 6218 - 6223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B Zimmermann, K. Connolly, M. Bozo, J. Bridson, F. Rohner, and L. Grimci Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a randomized, controlled, double-blind study Am. J. Clinical Nutrition, January 1, 2006; 83(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Biebermann, P. Ambrugger, P. Tarnow, A. von Moers, U. Schweizer, and A. Grueters Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8 Eur. J. Endocrinol., September 1, 2005; 153(3): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Van der Geyten and V M Darras Developmentally defined regulation of thyroid hormone metabolism by glucocorticoids in the rat J. Endocrinol., May 1, 2005; 185(2): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sui, W. L. Anderson, and M. E. Gilbert Impairment in Short-Term but Enhanced Long-Term Synaptic Potentiation and ERK Activation in Adult Hippocampal Area CA1 Following Developmental Thyroid Hormone Insufficiency* Toxicol. Sci., May 1, 2005; 85(1): 647 - 656. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
